Arcturus Therapeutics Holdings Inc. financial data

Symbol
ARCT on Nasdaq
Industry
Pharmaceutical Preparations
Location
10628 Science Center Drive, Suite 250, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 402 % -1.21%
Debt-to-equity 51.2 % -7.44%
Return On Equity -23.6 % -169%
Return On Assets -15.6 % -171%
Operating Margin -50.2 % -342%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.1M shares +1.36%
Common Stock, Shares, Outstanding 27.1M shares +1.35%
Entity Public Float 692M USD +84.1%
Common Stock, Value, Issued 27K USD 0%
Weighted Average Number of Shares Outstanding, Basic 27.1M shares +1.84%
Weighted Average Number of Shares Outstanding, Diluted 27.1M shares +1.84%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 160M USD -45.9%
Research and Development Expense 188M USD +3.02%
General and Administrative Expense 53M USD +1.39%
Operating Income (Loss) -80.5M USD -231%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -62.4M USD -161%
Income Tax Expense (Benefit) 263K USD -90.5%
Net Income (Loss) Attributable to Parent -62.6M USD -163%
Earnings Per Share, Basic -2.34 USD/shares -162%
Earnings Per Share, Diluted -2.3 USD/shares -162%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 237M USD -24%
Accounts Receivable, after Allowance for Credit Loss, Current 30.2M USD -21%
Assets, Current 331M USD -15.9%
Property, Plant and Equipment, Net 10.4M USD -18.6%
Operating Lease, Right-of-Use Asset 27.6M USD -6.56%
Assets 371M USD -19%
Accounts Payable, Current 10.1M USD -44.8%
Employee-related Liabilities, Current 10.8M USD +6.33%
Accrued Liabilities, Current 32.4M USD +13.5%
Liabilities, Current 69.5M USD -20.8%
Operating Lease, Liability, Noncurrent 26M USD -3.82%
Other Liabilities, Noncurrent 497K USD -82.3%
Liabilities 109M USD -38.7%
Retained Earnings (Accumulated Deficit) -419M USD -17.6%
Stockholders' Equity Attributable to Parent 262M USD -6.5%
Liabilities and Equity 371M USD -19%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.56M USD +84.5%
Net Cash Provided by (Used in) Financing Activities 2.19M USD
Net Cash Provided by (Used in) Investing Activities -240K USD +65.3%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 27.1M shares +1.35%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.61M USD +94.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 294M USD -20.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.1M USD +1144%
Deferred Tax Assets, Valuation Allowance 109M USD +10.3%
Deferred Tax Assets, Gross 117M USD +9.25%
Operating Lease, Liability 29.4M USD -5.75%
Payments to Acquire Property, Plant, and Equipment 240K USD -65.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -62.6M USD -163%
Lessee, Operating Lease, Liability, to be Paid 35M USD -7.72%
Property, Plant and Equipment, Gross 21.3M USD +3.4%
Operating Lease, Liability, Current 3.44M USD -18.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.27M USD +31.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.81M USD -14.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.58M USD -16.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.13M USD +14.7%
Deferred Tax Assets, Operating Loss Carryforwards 19.1M USD -60%
Unrecognized Tax Benefits 3.6M USD +24.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.82M USD
Additional Paid in Capital 681M USD +6.99%
Share-based Payment Arrangement, Expense 37.8M USD +16.9%